Coherus Biosciences | CHRS - Market Capitalization

Stock Price
1.61
Daily Change
-0.40 -19.90%
Monthly
0.63%
Yearly
36.44%
Q1 Forecast
2.39

Coherus Biosciences reported $226.6M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Akebia Therapeutics USD 322M 180M Jun/2025
ALKERMES USD 5.65B 696M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amarin USD 341M 4M Sep/2025
Amgen USD 201.45B 25.2B Feb/2026
Baxter International USD 9.54B 279M Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Coherus Biosciences USD 278M 184M Jun/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Fujifilm JPY 3.64T 386.71B Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026
Xencor USD 837M 278M Sep/2025
Zoetis USD 57.53B 2.08B Feb/2026